Quick Answer
Vir Biotechnology, Inc. reported Total Revenue of $68.56 million for fiscal year 2025.
Vir Biotechnology, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $68.56M | -7.6% |
| 2024 | $74.20M | -13.9% |
| 2023 | $86.18M | -94.7% |
| 2022 | $1.62B | +47.5% |
| 2021 | $1.10B | +1334.4% |
| 2020 | $76.37M | +843.9% |
| 2019 | $8.09M | -24.2% |
| 2018 | $10.67M | +293.9% |
| 2017 | $2.71M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $240.0K | -89.9% | -80.2% |
| June 30, 2025 | $1.21M | -60.5% | -60.0% |
| March 31, 2025 | $3.03M | -94.6% | +27.4% |
| September 30, 2024 | $2.38M | -9.8% | -22.6% |
| June 30, 2024 | $3.08M | -19.0% | -94.5% |
| March 31, 2024 | $56.38M | -10.5% | +2036.3% |
| September 30, 2023 | $2.64M | -99.3% | -30.5% |
| June 30, 2023 | $3.80M | +109.3% | -94.0% |
- Vir Biotechnology, Inc. showed a decrease of -7.6% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Vir Biotechnology, Inc.’s total revenue has grown by 2431.6% (from $2.71 million to $68.56 million).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: